• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻微肝性脑病的管理方案。

Management options for minimal hepatic encephalopathy.

作者信息

Bajaj Jasmohan S

机构信息

Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, 1201 Broad Rock Boulevard, Richmond, VA 23221, USA.

出版信息

Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):785-90. doi: 10.1586/17474124.2.6.785.

DOI:10.1586/17474124.2.6.785
PMID:19090738
Abstract

Minimal hepatic encephalopathy (MHE) is a neurocognitive dysfunction that is present in the majority of patients with cirrhosis. MHE has a characteristic cognitive profile that cannot be diagnosed clinically. This cognitive dysfunction is independent of sleep dysfunction or problems with overall intelligence. MHE has a significant impact on quality of life, the ability to function in daily life and progression to overt hepatic encephalopathy. Driving ability can be impaired in MHE and this may be a significant factor behind motor vehicle accidents. A crucial aspect of the clinical care of MHE patients is their driving history, which is often ignored during routine care and can add a vital dimension to the overall disease assessment. Driving history should be an integral part of the care of patients with MHE. The preserved communication skills and lack of specific signs and insight make MHE difficult to diagnose. The predominant strategies for MHE diagnosis are psychometric or neurophysiological testing. These are usually limited by financial, normative or time constraints. Studies into inhibitory control, cognitive drug research and critical flicker frequency tests are encouraging. These tests do not require a psychologist for administration and interpretation. Lactulose and probiotics have been studied for their potential use as therapies for MHE, but these are not standard-of-care practices at this time. Therapy can improve the quality of life in MHE patients but the natural history, specific diagnostic strategies and treatment options are still being investigated.

摘要

轻微肝性脑病(MHE)是一种神经认知功能障碍,存在于大多数肝硬化患者中。MHE具有一种临床无法诊断的特征性认知模式。这种认知功能障碍独立于睡眠功能障碍或整体智力问题。MHE对生活质量、日常生活功能以及进展为显性肝性脑病均有重大影响。MHE患者的驾驶能力可能受损,这可能是机动车事故背后的一个重要因素。MHE患者临床护理的一个关键方面是他们的驾驶史,而这在常规护理中常常被忽视,并且可为整体疾病评估增添至关重要的维度。驾驶史应成为MHE患者护理的一个组成部分。MHE患者保留的沟通能力以及缺乏特定体征和自知力使得其难以诊断。MHE诊断的主要策略是心理测量或神经生理学测试。这些测试通常受到资金、规范性或时间限制。对抑制控制、认知药物研究和临界闪烁频率测试的研究令人鼓舞。这些测试不需要心理学家进行管理和解读。乳果糖和益生菌已被研究其作为MHE治疗方法的潜在用途,但目前这些并非标准治疗方法。治疗可改善MHE患者的生活质量,但自然病程、具体诊断策略和治疗选择仍在研究中。

相似文献

1
Management options for minimal hepatic encephalopathy.轻微肝性脑病的管理方案。
Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):785-90. doi: 10.1586/17474124.2.6.785.
2
Minimal hepatic encephalopathy matters in daily life.轻微肝性脑病影响日常生活。
World J Gastroenterol. 2008 Jun 21;14(23):3609-15. doi: 10.3748/wjg.14.3609.
3
Minimal hepatic encephalopathy.轻微肝性脑病
J Assoc Physicians India. 2009 Nov;57:760-3.
4
Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.临界闪烁频率诊断和评估肝硬化患者轻微肝性脑病的恢复。
Hepatobiliary Pancreat Dis Int. 2010 Feb;9(1):27-32.
5
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.一项比较乳果糖、益生菌和 L-鸟氨酸 L-天冬氨酸治疗轻微型肝性脑病的随机对照试验。
Eur J Gastroenterol Hepatol. 2011 Aug;23(8):725-32. doi: 10.1097/MEG.0b013e32834696f5.
6
Minimal hepatic encephalopathy.轻微肝性脑病
Nat Clin Pract Gastroenterol Hepatol. 2007 Dec;4(12):677-85. doi: 10.1038/ncpgasthep0999.
7
An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.乳果糖和益生菌治疗轻微肝性脑病的开放标签随机对照试验
Eur J Gastroenterol Hepatol. 2008 Jun;20(6):506-11. doi: 10.1097/MEG.0b013e3282f3e6f5.
8
Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.肝硬化患者轻微肝性脑病对乳果糖无反应的预测因素
Liver Int. 2009 Oct;29(9):1365-71. doi: 10.1111/j.1478-3231.2009.02067.x. Epub 2009 Jun 23.
9
Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?如果我们不对肝硬化患者进行轻微肝性脑病筛查,这算是医疗失误吗?
Rev Esp Enferm Dig. 2002 Sep;94(9):544-57.
10
Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.演变的概念:轻微肝性脑病的负面影响和肝硬化患者预防的作用。
Clin Ther. 2013 Sep;35(9):1458-73. doi: 10.1016/j.clinthera.2013.07.421. Epub 2013 Aug 22.

引用本文的文献

1
Hepatic Encephalopathy among Patients with Chronic Liver Disease Admitted to the Department of Internal Medicine in a Tertiary Care Centre: A Descriptive Cross-sectional Study.三级医疗中心内科收治的慢性肝病患者中的肝性脑病:一项描述性横断面研究
JNMA J Nepal Med Assoc. 2023 Jul;61(263):580-583. doi: 10.31729/jnma.8206. Epub 2023 Jul 30.
2
EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients.EncephalApp 斯特鲁普测验用于突尼斯肝硬化患者隐匿性肝性脑病的筛查。
F1000Res. 2023 Sep 1;11:686. doi: 10.12688/f1000research.121781.2. eCollection 2022.
3
Hepatic Encephalopathy following Transjugular Intrahepatic Portosystemic Shunt Placement.
经颈静脉肝内门体分流术后肝性脑病
Semin Intervent Radiol. 2023 Jul 20;40(3):262-268. doi: 10.1055/s-0043-1769770. eCollection 2023 Jun.
4
Effects of Low-dose and High-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy.低剂量和高剂量利福昔明治疗隐性肝性脑病的效果
J Clin Transl Hepatol. 2022 Dec 28;10(6):1099-1106. doi: 10.14218/JCTH.2021.00457. Epub 2022 Feb 14.
5
The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.肠道细菌和肠脑轴在肝性脑病中的作用。
Front Cell Infect Microbiol. 2021 Jan 21;10:595759. doi: 10.3389/fcimb.2020.595759. eCollection 2020.
6
The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis.肝性脑病与糖尿病性脑病的关系:脑-肝轴。
Int J Mol Sci. 2021 Jan 5;22(1):463. doi: 10.3390/ijms22010463.
7
Fibroblast Growth Factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells.成纤维细胞生长因子-21通过激活STAT3-SOCS3通路抑制活化的肝星状细胞来改善肝性脑病。
EXCLI J. 2020 May 4;19:567-581. doi: 10.17179/excli2020-1287. eCollection 2020.
8
Outcome of non-surgical dietary treatment with or without lactulose in dogs with congenital portosystemic shunts.先天性门静脉分流犬采用或不采用乳果糖的非手术饮食治疗结果。
Vet Q. 2020 Dec;40(1):108-114. doi: 10.1080/01652176.2020.1745928.
9
Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy.肝硬化伴发的肌肉减少症和认知功能障碍:轻微型肝性脑病临床影响的观点。
World J Gastroenterol. 2019 Sep 21;25(35):5257-5265. doi: 10.3748/wjg.v25.i35.5257.
10
Quality of life in patients with minimal hepatic encephalopathy.轻微肝性脑病患者的生活质量。
World J Gastroenterol. 2018 Dec 28;24(48):5446-5453. doi: 10.3748/wjg.v24.i48.5446.